The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Open accessAbstract
BACKGROUND: Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation frequently recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence, but the effect of these drugs on mortality and other clinical outcomes is unclear. This is an update of a review previously published in 2008 and 2012. OBJECTIVES: To determine in patients who have recovered sinus rhythm after having atrial fibrillation, the effects of long-term treatment with antiarrhythmic drugs on death, stroke, embolism, drug adverse effects and recurrence of atrial fibrillation. SEARCH METHODS: We updated the searches of CENTRAL in The Cochrane Library (2013, Issue 12 of 12), MEDLINE (to January 2014) and EMBASE (to January 2014). The reference lists of retrieved articles, recent reviews and meta-analyses were checked. SELECTION CRITERIA: Two independent authors selected randomised controlled trials comparing any antiarrhythmic drug with a control (no treatment, placebo, drugs for rate control) or with another antiarrhythmic drug in adults who had atrial fibrillation and in whom sinus rhythm was restored. Post-operative atrial fibrillation was excluded. DATA COLLECTION AND ANALYSIS: Two authors independently assessed quality and extracted data. Studies were pooled, if appropriate, using Peto odds ratio (OR). All results were calculated at one year of follow-up. MAIN RESULTS: In this update three new studies, with 534 patients, were included making a total of 59 included studies comprising 21,305 patients. All included studies were randomised controlled trials. Allocation concealment was adequate in 17 trials, it was unclear in the remaining 42 trials. Risk of bias was assessed in all domains only in the trials included in this update.Compared with controls, class IA drugs quinidine and disopyramide (OR 2.39, 95% confidence interval (95% CI) 1.03 to 5.59, number needed to treat to harm (NNTH) 109, 95% CI 34 to 4985) and sotalol (OR 2.23, 95% CI 1.1 to 4.50, NNTH 169, 95% CI 60 to 2068) were associated with increased all-cause mortality. Other antiarrhythmics did not seem to modify mortality, but our data could be underpowered to detect mild increases in mortality for several of the drugs studied.Several class IA (disopyramide, quinidine), IC (flecainide, propafenone) and III (amiodarone, dofetilide, dronedarone, sotalol) drugs significantly reduced recurrence of atrial fibrillation (OR 0.19 to 0.70, number needed to treat to beneft (NNTB) 3 to 16). Beta-blockers (metoprolol) also significantly reduced atrial fibrillation recurrences (OR 0.62, 95% CI 0.44 to 0.88, NNTB 9).All analysed drugs increased withdrawals due to adverse affects and all but amiodarone, dronedarone and propafenone increased pro-arrhythmia. Only 11 trials reported data on stroke. None of them found any significant difference with the exception of a single trial than found less strokes in the group treated with dronedarone compared to placebo. This finding was not confirmed in others studies on dronedarone.We could not analyse heart failure and use of anticoagulation because few original studies reported on these measures. AUTHORS' CONCLUSIONS: Several class IA, IC and III drugs, as well as class II drugs (beta-blockers), are moderately effective in maintaining sinus rhythm after conversion of atrial fibrillation. However, they increase adverse events, including pro-arrhythmia, and some of them (disopyramide, quinidine and sotalol) may increase mortality. Possible benefits on clinically relevant outcomes (stroke, embolism, heart failure) remain to be established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacological cardioversion for atrial fibrillation and flutter
Cordina, J., & Mead, G. E. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003713.pub2 · Cited by 35
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Métayer, P., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 7,975
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
(2008) · Cited by 3,790
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
The AFFIRM Investigators (2004) · Circulation · doi:10.1161/01.cir.0000121736.16643.11 · Cited by 1,206
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Hohnloser, S. H., Kuck, K.-H., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,134
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Conceptual and technical challenges in network meta-analysis
Cipriani, A., Higgins, J. P. T., Geddes, J. R., & Salanti, G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00008 · Cited by 1,072
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
Oral, H., Pappone, C., Chugh, A., Good, E., Bogun, F., Pelosi, F., Bates, E. R., Lehmann, M. H., Vicedomini, G., Augello, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050955 · Cited by 976
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
Køber, L., Torp-Pedersen, C., McMurray, J. J. V., Gøtzsche, O., Lévy, S., Crijns, H., Amlie, J., & Carlsen, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800456 · Cited by 972
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 945
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation
Carlsson, J. Ö., Miketic, S., Windeler, J. Ü., Cuneo, A., Haun, S., Micus, S., Walter, S., & Tebbe, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00332-2 · Cited by 941
Di Biase, L., Mohanty, P., Mohanty, S., Santangeli, P., Trivedi, C., Lakkireddy, D., Reddy, M., Jais, P., Themistoclakis, S., Dello Russo, A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019406 · Cited by 867
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
WILLIAMS, E. M. V. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01822.x · Cited by 818
Amiodarone versus sotalol for atrial fibrillation
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041705 · Cited by 749
Pappone, C., Augello, G., Sala, S., Gugliotta, F., Vicedomini, G., Gulletta, S., Paglino, G., Mazzone, P., Sora, N., Greiss, I., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.037 · Cited by 686
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
Flaker, G. C., Blackshear, J. L., McBride, R., Kronmal, R. A., Halperin, J. L., & Hart, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90003-6 · Cited by 632
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., & Hohnloser, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054686 · Cited by 631
Deedwania, P. C., Singh, B. N., Ellenbogen, K., Fisher, S., Fletcher, R., & Singh, S. N. (1998) · Circulation · doi:10.1161/01.cir.98.23.2574 · Cited by 506
Wattigney, W. A., Mensah, G. A., & Croft, J. B. (2003) · Circulation · doi:10.1161/01.cir.0000083722.42033.0a · Cited by 505
Pedersen, O. D., Bagger, H., Keller, N., Marchant, B., Køber, L., & Torp-Pedersen, C. (2001) · Circulation · doi:10.1161/01.cir.104.3.292 · Cited by 496
Outpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach
Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479
Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation
Opolski, G., Torbicki, A., Kosior, D. A., Szulc, M., Wozakowska-Kapłon, B., Kołodziej, P., & Achremczyk, P. (2004) · Chest · doi:10.1378/chest.126.2.476 · Cited by 473
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433
Mont, L., Bisbal, F., Hernández-Madrid, A., Pérez-Castellano, N., Viñolas, X., Arenal, A., Arribas, F., Fernández-Lozano, I., Bodegas, A., Cobos, A., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht457 · Cited by 394
LE HEUZEY, J., DE FERRARI, G. M., RADZIK, D., SANTINI, M., ZHU, J., & DAVY, J. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01764.x · Cited by 386
Side effects of long-term amiodarone therapy.
Harris, L., McKenna, W. J., Rowland, E., Holt, D. W., Storey, G. C., & Krikler, D. M. (1983) · Circulation · doi:10.1161/01.cir.67.1.45 · Cited by 358
Juul-Möller, S., Edvardsson, N., & Rehnqvist-Ahlberg, N. (1990) · Circulation · doi:10.1161/01.cir.82.6.1932 · Cited by 341
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
Touboul, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00321-x · Cited by 315
Lafuente-Lafuente, C., Mouly, S., Longás-Tejero, M. A., Mahé, I., & Bergmann, J.-F. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.719 · Cited by 288
Self-citationAnderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Maintenance of sinus rhythm in patients with atrial fibrillation
(2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00559-x · Cited by 281
Gosselink, A. T. M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480240051033 · Cited by 281
Connolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Kühlkamp, V., Schirdewan, A., Stangl, K., Homberg, M., Ploch, M., & Beck, O. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00693-8 · Cited by 256
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
Reimold, S. C., Cantillon, C. O., Friedman, P. L., & Antman, E. M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90511-a · Cited by 253
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation
Dorian, P., Paquette, M., Newman, D., Green, M., Connolly, S. J., Talajic, M., & Roy, D. (2002) · American Heart Journal · doi:10.1067/mhj.2002.122518 · Cited by 247
Freemantle, N., Lafuente-Lafuente, C., Mitchell, S., Eckert, L., & Reynolds, M. (2011) · Europace · doi:10.1093/europace/euq450 · Cited by 245
Gelder, I. C. V. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.22.2585 · Cited by 241
Rate vs Rhythm Control in Patients With Atrial Fibrillation: A Meta-analysis
de Denus, S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.258 · Cited by 239
Piccini, J. P., Hasselblad, V., Peterson, E. D., Washam, J. B., Califf, R. M., & Kong, D. F. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.085 · Cited by 222
Amiodarone for refractory atrial fibrillation
Gold, R. L., Haffajee, C. I., Charos, G., Sloan, K., Baker, S., & Alpert, J. S. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90964-1 · Cited by 218
Chun, S. H., Sager, P. T., Stevenson, W. G., Nademanee, K., Middlekauff, H. R., & Singh, B. N. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80799-1 · Cited by 211
Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation J-RHYTHM Study
Ogawa, S., Yamashita, T., Yamazaki, T., Aizawa, Y., Atarashi, H., Inoue, H., Ohe, T., Ohtsu, H., Okumura, K., Katoh, T., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0608 · Cited by 205
Hohnloser, S. H., van de Loo, A., & Baedeker, F. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00286-5 · Cited by 204
Incidence of chronic atrial fibrillation in general practice and its treatment pattern
Ruigómez, A., Johansson, S., Wallander, M.-A., & Rodrı́guez, L. A. G. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00478-4 · Cited by 193
Van Gelder, I. C., Crijns, H. J. G. M., Van Gilst, W. H., Van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187
GRONEFELD, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00261-6 · Cited by 184
Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176
Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation
Chung, M. K., Shemanski, L., Sherman, D. G., Greene, H. L., Hogan, D. B., Kellen, J. C., Kim, S. G., Martin, L. W., Rosenberg, Y., & Wyse, D. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.040 · Cited by 173
Antman, E. M., Beamer, A. D., Cantillon, C., McGowan, N., & Friedman, P. L. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90649-a · Cited by 170
Page, R. L., Tilsch, T. W., Connolly, S. J., Schnell, D. J., Marcello, S. R., Wilkinson, W. E., & Pritchett, E. L. C. (2003) · Circulation · doi:10.1161/01.cir.0000051455.44919.73 · Cited by 166
Benditt, D. G., Williams, J. H., Jin, J., Deering, T. F., Zucker, R., Browne, K., Chang-Sing, P., & Singh, B. N. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00275-1 · Cited by 165
Frick, M., Frykman, V., Jensen‐Urstad, M., Östergren, J., & Rosenqvist, M. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240313 · Cited by 164
Van Gelder, I. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440210109011 · Cited by 163
Horowitz, L. N., Spielman, S. R., Greenspan, A. M., Mintz, G. S., Morganroth, J., Brown, R., Brady, P. M., & Kay, H. R. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80232-1 · Cited by 159
Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial
PATTEN, M., MAAS, R., BAUER, P., LUDERITZ, B., SONNTAG, F., DLUZNIEWSKI, M., HATALA, R., OPOLSKI, G., MULLER, H., & MEINERTZ, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.014 · Cited by 157
Flaker, G. C., The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators, Fletcher, K. A., Rothbart, R. M., Halperin, J. L., & Hart, R. G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80100-3 · Cited by 156
Brodsky, M. A., Allen, B. J., Walker, C. J., Casey, T. P., Luckett, C. R., & Henry, W. L. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90307-9 · Cited by 154
Terasawa, T., Balk, E. M., Chung, M., Garlitski, A. C., Alsheikh-Ali, A. A. A., Lau, J., & Ip, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00131 · Cited by 148
The AF-CHF Trial Investigators (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)00129-1 · Cited by 148
Södermark, T., Jönsson, B., Olsson, A. G., Orö, L., Wallin, H., Edhag, O., Sjögren, A., Danielsson, M., & Rosenhamer, G. (1975) · Heart · doi:10.1136/hrt.37.5.486 · Cited by 142
Darkner, S., Chen, X., Hansen, J., Pehrson, S., Johannessen, A., Nielsen, J. B., & Svendsen, J. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu354 · Cited by 142
Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
Testa, L., Biondi‐Zoccai, G., Russo, A. D., Bellocci, F., Andreotti, F., & Crea, F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi306 · Cited by 138
Karlson, B. W., Torstensson, I., Abjörn, C., Jansson, S.-O., & PETERSON|, L. E. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062498 · Cited by 137
Naccarelli, G. V., Dorian, P., Hohnloser, S. H., & Coumel, P. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89118-7 · Cited by 134
Knuiman, M. W., Briffa, T. G., Divitini, M., Chew, D. P., Eikelboom, J. W., McQuillan, B., & Hung, J. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-013-9875-y · Cited by 129
Nichol, G., McAlister, F. A., Pham, B., Laupacis, A., Shea, B., Green, M. S., Tang, A., & Wells, G. (2002) · Heart · doi:10.1136/heart.87.6.535 · Cited by 127
Efficacy of amiodarone for refractory supraventricular tachyarrhythmias
Graboys, T. B., Podrid, P. J., & Lown, B. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90009-1 · Cited by 125
Propafenone for Conversion and Prophylaxis of Atrial Fibrillation
Stroobandt, R., Stiels, B., & Hoebrechts, R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00779-5 · Cited by 118
Antman, E. M., Beamer, A. D., Cantillon, C. O., McGowan, N. E., Goldman, L., & Friedman, P. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90468-8 · Cited by 116
Zehender, M., Hohnloser, S. H., Müller, B. W., Meinertz, T., & Just, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90294-w · Cited by 115
CHATTERJEE, S., SARDAR, P., LICHSTEIN, E., MUKHERJEE, D., & AIKAT, S. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03513.x · Cited by 113
Plewan, A., Lehmann, G., Ndrepepa, G., Schreieck, J., Alt, E. U., Schömig, A., & Schmitt, C. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2546 · Cited by 110
Pritchett, E. L. C., Page, R. L., Carlson, M. D., Undesser, K. P., & Fava, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00974-3 · Cited by 105
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response
Pritchett, E. L. C., Page, R. L., Connolly, S. J., Marcello, S. R., Schnell, D., & Wilkinson, W. E. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00773-7 · Cited by 102
Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion
Härtel, G., Louhija, A., & Konttinen, A. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974156551 · Cited by 102
Hillestad, L., Bjerkelund, C. J., Dale, J., Maltau, J. M., & Storstein, O. (1971) · Heart · doi:10.1136/hrt.33.4.518 · Cited by 98
Allot, E., & Denjoy, I. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89120-5 · Cited by 98
KOCHIADAKIS, G. E., Igoumenidis, N. E., Marketou, M. E., Kaleboubas, M. D., Simantirakis, E. N., & Vardas, P. E. (2000) · Heart · doi:10.1136/heart.84.3.251 · Cited by 97
Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.
Vitolo, E., Tronci, M., Larovere, M. T., Rumolo, R., & Morabito, A. (1981) · PubMed · Cited by 97
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Longás-Tejero, M. A., Bergmann, J., & Belmin, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub3 · Cited by 96
Self-citationKhan, A. R., Khan, S., Sheikh, M. A., Khuder, S., Grubb, B. P., & Moukarbel, G. V. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001853 · Cited by 93
Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation
Berns, E., Rinkenberger, R. L., Jeang, M. K., DOUGHERTY, A. H., Jenkins, M., & Naccarelli, G. V. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90915-5 · Cited by 92
Golzari, H., Cebul, R. D., & Bahler, R. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00010 · Cited by 92
Miller, M. R., McNamara, R. L., Segal, J. B., Kim, N. H., Robinson, K. A., Goodman, S. N., Powe, N. R., & Bass, E. B. (2000) · PubMed · Cited by 91
Byrne-Quinn, E., & Wing, A. J. (1970) · Heart · doi:10.1136/hrt.32.3.370 · Cited by 89
Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter
Pietersen, A. H., & Hellemann, H. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90527-r · Cited by 88
Wanless, R. S., Anderson, K. P., Joy, M. D., & Joseph, S. P. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70186-8 · Cited by 87
Amiodarone in the Management of Refractory Atrial Fibrillation
Blevins, R. D., Kerin, N. Z., Benaderet, D., Frumin, H., Faitel, K., Jarandilla, R., & Rubenfire, M. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370080037009 · Cited by 86
Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation
Singh, S., Saini, R. K., Dimarco, J., Kluger, J., Gold, R. L., & Chen, Y. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90200-5 · Cited by 85
Low-Dose Amiodarone Versus Sotalol for Suppression of Recurrent Symptomatic Atrial Fibrillation
KOCHIADAKIS, G. E., Igoumenidis, N. E., Marketou, M. E., Solomou, M. C., KANOUPAKIS, E. M., & Vardas, P. E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00078-2 · Cited by 84
Bellandi, F., Simonetti, I., Leoncini, M., Frascarelli, F., Giovannini, T., Maioli, M., & Dabizzi, R. P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01806-9 · Cited by 83
Enriquez, A. A., Conde, D. G., Hopman, W. M., Mondragón, I., Chiale, P. A., de Luna, A. B., & Baranchuk, A. M. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12063 · Cited by 83
Fragakis, N., Koskinas, K. C., Katritsis, D. G., Pagourelias, E. D., Zografos, T., & Geleris, P. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.044 · Cited by 82
Clémenty, J., Dulhoste, M. N., Laiter, C., Denjoy, I., & Santos, P. D. D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91077-h · Cited by 82
Crijns, H. J. G. M., Gosselink, A. T. M., & Lie, K. I. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00823592 · Cited by 82
Usefulness of propafenone for recurrent paroxysmal atrial fibrillation
Connolly, S. J., & Hoffert, D. L. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90049-0 · Cited by 82
Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.
Härtel, G., Louhija, A., Konttinen, A., & Halonen, P. I. (1970) · Heart · doi:10.1136/hrt.32.1.57 · Cited by 81
Meinertz, T., Lip, G. Y. H., Lombardi, F., Sadowski, Z., Kalsch, B., Camez, A. A., Hewkin, A. C., & Eberle, S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02867-9 · Cited by 81
Channer, K. S. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.020 · Cited by 81
Connolly, S. J., Schnell, D., Page, R. L., Wilkinson, W. E., Marcello, S. R., & Pritchett, E. L. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01973-7 · Cited by 80
Caldeira, D., David, C., & Sampaio, C. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.11.005 · Cited by 79
Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity
Lafuente‐Lafuente, C., Alvarez, J., Leenhardt, A., Mouly, S. J., Extramiana, F., Caulin, C., Funck‐Brentano, C., & Bergmann, J. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03381.x · Cited by 79
Self-citationCHIMIENTI, M., The Flecainide and Propafenone Italian Study (FAPIS) Investigators, Cullen, M. T., & Casadei, G. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89119-9 · Cited by 78
Simone, A. D. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00311-7 · Cited by 75
Opolski, G., Stanisławska, J., Górecki, A., Świěcicka, G., Kraska, T., & Torbicki, A. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200407 · Cited by 73
Friedman, P. L., & Stevenson, W. G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00586-4 · Cited by 71
Yamashita, T., Ogawa, S., Sato, T., Aizawa, Y., Atarashi, H., Fujiki, A., Inoue, H., Ito, M., Katoh, T., Kobayashi, Y., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1061 · Cited by 70
Steeds, R. P., Birchall, A., Smith, M., & Channer, K. (1999) · Heart · doi:10.1136/hrt.82.2.170 · Cited by 70
Galperín, J., Elizari, M. V., Chiale, P. A., Molina, R. T., Ledesma, R., Scapín, A. O., & Blanco, M. V. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600403 · Cited by 68
Boissel, J., WOLF, E., GILLET, J., SOUBRANU, A., Cavallaro, A., Mazoyer, G., & DULAHYE, J. P. (1981) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061163 · Cited by 68
Propafenone for paroxysmal atrial fibrillation
Hammill, S. C., Wood, D. L., Gersh, B. J., Osborn, M. J., & Holmes, D. R. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90312-8 · Cited by 66
Nergardh, A. K., Rosenqvist, M., Nordlander, R., & Frick, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl544 · Cited by 65
Manios, E. G., Mavrakis, H. E., KANOUPAKIS, E. M., Kallergis, E. M., Dermitzaki, D., Kambouraki, D. C., & Vardas, P. E. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1024203824761 · Cited by 64
Therapeutic efficacy and safety of oral propafenone for atrial fibrillation
Porterfield, J. G., & Porterfield, L. M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)91091-6 · Cited by 64
CHIMIENTI, M., CULLEN, M. T., & Casadei, G. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060852 · Cited by 64
The AFFIRM Investigators (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.06.034 · Cited by 63
Propafenone for prevention of recurrent atrial fibrillation
Kerr, C. R., Klein, G. J., Axelson, J. E., & Cooper, J. C. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90373-6 · Cited by 62
Lloyd, E. A., Bj, G., & Forman, R. (1984) · PubMed · Cited by 60
Extending Treatment Networks in Health Technology Assessment: How Far Should We Go?
Caldwell, D. M., Dias, S., & Welton, N. J. (2015) · Value in Health · doi:10.1016/j.jval.2015.03.1792 · Cited by 56
Møller, M., Torp-Pedersen, C. T., Køber, L., & on behalf of the Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group (2001) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2001.00243.x · Cited by 56
Kochiadakis, G. E., Marketou, M. E., Igoumenidis, N. E., Chrysostomakis, S. I., Mavrakis, H. E., KALEBOUBAS, M. D., & Vardas, P. E. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb07044.x · Cited by 55
Flecainide Versus Quinidine in the Prevention of Paroxysms of Atrial Fibrillation
van Wijk, L. M., den Heijer, P., Crijns, H. J. G. M., van Gilst, W. H., & Lie, K. I. (1989) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198901000-00005 · Cited by 54
Hopson, J. R., Buxton, A. E., Rinkenberger, R. L., Nademanee, K., Heilman, J. M., & Kienzle, M. G. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89121-7 · Cited by 54
Singh, S. N., Singh, B. N., Reda, D. J., Fye, C. L., Ezekowitz, M. D., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00671-4 · Cited by 49
Flecainide acetate for paroxysmal supraventricular tachyarrhythmias
Anderson, J. L., Platt, M. L., Guarnieri, T., Fox, T. L., Maser, M. J., & Pritchett, E. L. C. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90747-1 · Cited by 48
Wong, C., White, H. D., Wilcox, R. G., et al. (2002) · Heart · doi:10.1136/heart.88.4.357 · Cited by 48
Lau, C., Leung, W., & Wong, C. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90272-w · Cited by 46
Lombardi, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl209 · Cited by 46
KOCHIADAKIS, G. E., Igoumenidis, N. E., Hamilos, M. I., Tzerakis, P. G., Klapsinos, N. C., Zacharis, E. A., & Vardas, P. E. (2004) · CHEST Journal · doi:10.1378/chest.125.2.377 · Cited by 45
Catheter ablation for paroxysmal and persistent atrial fibrillation
Chen, H. S., Wen, J., Wu, S., & Liu, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007101.pub2 · Cited by 43
Chatterjee, S., Ghosh, J., Lichstein, E., Aikat, S., & Mukherjee, D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.034 · Cited by 42
KANOUPAKIS, E. M., Manios, E. G., Mavrakis, H. E., Tzerakis, P. G., Mouloudi, H. K., & Vardas, P. E. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.037 · Cited by 42
de Paola, Â. A. V., & Veloso, H. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00494-4 · Cited by 41
Pharmacological and Electrical Conversion of Atrial Fibrillation to Sinus Rhythm Is Worth the Effort
Anter, E., Callans, D. J., & Wyse, D. G. (2009) · Circulation · doi:10.1161/circulationaha.108.824847 · Cited by 39
Pritchett, E. L. C., Kowey, P. R., Connolly, S. J., Page, R. L., Kerr, C. R., & Wilkinson, W. E. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.019 · Cited by 39
Torp-Pedersen, C. T., Raev, D. H., Dickinson, G. E., Butterfield, N. N., Mangal, B., & Beatch, G. N. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962340 · Cited by 38
Anderson, J. L., & The Flecainide Supraventricular Tachyarrhythmia Investigators (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91072-c · Cited by 37
Gulizia, M. M., Mangiameli, S., Orazi, S., Chiarandà, G., Piccione, G., Giovanni, N. D., Colletti, A., Pensabene, O., Lisi, F., Vasquez, L., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.033 · Cited by 34
Vijayalakshmi, K., Whittaker, V., Sutton, A. G. C., Campbell, P. G., Wright, R. A., Hall, J. A., Harcombe, A., Linker, N. J., Stewart, M. J., Davies, A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.009 · Cited by 34
Saborido, C. M., Hockenhull, J., Bagust, A., Boland, A., Dickson, R., & Todd, D. (2010) · Health Technology Assessment · doi:10.3310/hta14310 · Cited by 34
Page, R. L., Connolly, S. J., Wilkinson, W. E., Marcello, S. R., Schnell, D., & Pritchett, E. L. C. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120969 · Cited by 34
Kerr, C. R., Connolly, S. J., Kowey, P. R., Page, R. L., Pritchett, E. L. C., Ruda, M. Y., Rużyłło, W., & Wilkinson, W. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.084 · Cited by 33
Lumer, G. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2986 · Cited by 33
Sullivan, S. D., Orme, M. E., Morais, E., & Mitchell, S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.070 · Cited by 32
Ishiguro, H., Ikeda, T., Abe, A., Tsukada, T., Mera, H., Nakamura, K., Yusu, S., & Yoshino, H. (2008) · International Heart Journal · doi:10.1536/ihj.49.281 · Cited by 31
KOCHIADAKIS, G. E., Igoumenidis, N. E., Hamilos, M. E., Tzerakis, P. G., Klapsinos, N. C., CHLOUVERAKIS, G. I., & Vardas, P. E. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.041 · Cited by 31
Okishige, K., Nishizaki, M., Azegami, K., Igawa, M., Yamawaki, N., & Aonuma, K. (2000) · American Heart Journal · doi:10.1067/mhj.2000.107174 · Cited by 31
Doğan, A., Ergene, O., Nazlı, C., Kınay, O., Altınbaş, A., Ucarci, Y., Ergene, Ü., Özaydın, M., & Gedikli, Ö. (2004) · Acta Cardiologica · doi:10.2143/ac.59.3.2005179 · Cited by 31
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation
Qin, D., Leef, G. C., Alam, M. B., Rattan, R., Munir, M. B., Patel, D. R., Khattak, F. H., ADELSTEIN, E. C., Jain, S. K., & Saba, S. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.07.001 · Cited by 29
Lodziński, P., Kiliszek, M., Koźluk, E., Piątkowska, A., Balsam, P., Kochanowski, J., Ścisło, P., Piątkowski, R., & Opolski, G. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0144 · Cited by 25
(2003) · PsycEXTRA Dataset · doi:10.1037/e307112005-002 · Cited by 25
Komatsu, T., Satō, Y., Tachibana, H., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.667 · Cited by 23
Atarashi, H., Inoue, H., Fukunami, M., Sugi, K., Hamada, C., Origasa, H., & for the Sinus Rhythm Maintenance in Atrial Fibrillation Randomized Trial (SMART) Investigators (2002) · Circulation Journal · doi:10.1253/circj.66.553 · Cited by 23
Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation.
Geleris, P., Stavrati, A., Afthonidis, D., Kirpizidis, H. G., & Boudoulas, H. (2001) · PubMed · Cited by 23
Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fi brillation
Gu, J., Liu, X., Tan, H., et al. (2012) · Acta cardiologica. Supplementum · doi:10.1080/ac.67.4.2170681 · Cited by 22
Feyrer, R., Ballazhi, F., Seitz, T., Weyand, M., & Harig, F. (2013) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.12.02233 · Cited by 22
Clinical Efficacy of Flecainide Acetate in Atrial Fibrillation
Mary-Rabine, L., & KULBERTUS, H. E. (2008) · Cardiology · doi:10.1159/000174636 · Cited by 20
Page, R. L., Pritchett, E. L. C., Connolly, S. J., Wilkinson, W. E., & For the SVA‐4 Investigators (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00985.x · Cited by 19
Connolly, S. J., Schnell, D., Page, R. L., Wilkinson, W. E., Marcello, S. R., & Pritchett, E. L. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00250-3 · Cited by 19
Maykov, E. B., Yuricheva, Y. A., Mironov, N. Y., Sokolov, S. F., Sp, G., Розенштраух, Л. В., & Chazov, E. I. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587138-48 · Cited by 19
Steinbeck, G., Doliwa, R., & Bach, P. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1067903 · Cited by 18
Treatment of Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia With Bidisomide
(1997) · Circulation · doi:10.1161/01.cir.96.8.2625 · Cited by 17
Die medikamentöse Prophylaxe nach elektronischer Kardioversion von chronischem Vorhofflimmern
Fetsch, T., Burschel, G., BREITHARDT, G. E., Engberding, R., Koch, H.-P., LUKL, J., Trappe, H.-J., & Treese, N. (1999) · Zeitschrift für Kardiologie · doi:10.1007/s003920050276 · Cited by 17
Carunchio, A., Fera, M. S., Mazza, A., Burattini, M., Greco, G., Galati, A., & Ceci, V. (1995) · PubMed · Cited by 17
Bellandi, F., Rp, D., Niccoli, L., Cantini, F., & Palchetti, R. (1996) · PubMed · Cited by 17
Chun, K. J., Byeon, K., Im, S. I., Park, K., Park, S., Kim, J. S., & On, Y. K. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.013 · Cited by 16
Appropriate outcome measures in trials evaluating treatment of atrial fibrillation
Connolly, S. J. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90002-4 · Cited by 16
Farkowski, M. M., Maciąg, A., Dąbrowski, R., Pytkowski, M., Kowalik, I., & Szwed, H. (2012) · Trials · doi:10.1186/1745-6215-13-162 · Cited by 16
Kalusche, D., Stockinger, J., Betz, P., & Roskamm, H. (1994) · PubMed · Cited by 15
Meng, Z., Tan, J., He, Q., Zhu, M. J., Li, X., Zhang, J., Jia, Q., Wang, S., Zhang, G., & Zheng, W. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/101904 · Cited by 15
Li, H., Riedel, R., Oldemeyer, J. B., Rovang, K. S., & Hee, T. T. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.010 · Cited by 15
Bellandi, F., Dabizzi, R. P., Niccoli, & Cantini, F. (1995) · Current Therapeutic Research · doi:10.1016/0011-393x(95)85125-9 · Cited by 14
Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter
Khitri, A., Aliot, E., Capucci, A., Connolly, S. J., Crijns, H. J. G. M., Hohnloser, S. H., Kułakowski, P., Roy, D., Radzik, D., & Kowey, P. R. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02234.x · Cited by 12
Zeriouh, M., Sabashnikov, A., Choi, Y., Fatullayev, J., Reuter, H., Popov, A., Langebartels, G., Kimmig, L. M., Rahmanian, P. B., Wittwer, T., et al. (2014) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-9-83 · Cited by 11
Die medikamentöse Anfallsprophylaxe bei symptomatischem paroxysmalem Vorhofflimmern/-flattern
Patten, M., Koch, H.-P., Sonntag, F., Lüderitz, B., & Meinertz, T. (1999) · Zeitschrift für Kardiologie · doi:10.1007/s003920050275 · Cited by 11
Juanatey, J. R. G., Sampedro, F. G., Roub?n, S. R., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs282 · Cited by 11
(2011) · European Heart Journal · doi:10.1093/eurheartj/ehr323 · Cited by 9
Usefulness of Dronedarone in Patients With Atrial Arrhythmias
Löbe, S., Salmáš, J., John, S., Kornej, J., Husser, D., Hindricks, G., & Bollmann, A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.057 · Cited by 8
Babuty, D., Maison‐Blanche, P., Fauchier, L., et al. (1999) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.1999.tb00365.x · Cited by 8
Long term efficacy of propafenone for prevention of atrial fibrillation.
Kyles, A. E., Murdock, C. J., Yeung‐Lai‐Wah, J. A., et al. (1991) · PubMed · Cited by 7
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Metadata
- Authors
- Lafuente-Lafuente, C., Valembois, L., Bergmann, J.-F., & Belmin, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-03-28
- Volume
- 9
- Issue
- 3
- Pages
- CD005049-CD005049
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2109318634
- Cited by
- 423
- References
- 203
- FWCI
- 24.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.